Page last updated: 2024-08-21

alpha-aminopyridine and Cardio-Cutaneous Syndrome

alpha-aminopyridine has been researched along with Cardio-Cutaneous Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbadessa, G; Chandrasekhar, V; Kontaridis, MI; Schwartz, B; Wang, J; Yu, Y1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Cardio-Cutaneous Syndrome

ArticleYear
In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy.
    PloS one, 2017, Volume: 12, Issue:6

    Topics: Alleles; Aminopyridines; Animals; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Disease Models, Animal; Echocardiography; Gene Expression Regulation; Humans; Imidazoles; LEOPARD Syndrome; Male; Mice; Mice, Transgenic; Mutation; Myocytes, Cardiac; Phosphoproteins; Protein Domains; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases

2017